Denali Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Balyasny Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $226k | 17k | 13.60 |
| 2024-12-31 | $8.5M | 416k | 20.38 |
| 2024-09-30 | $1.3M | 45k | 29.13 |
| 2024-06-30 | $2.8M | 121k | 23.22 |
| 2024-03-31 | $7.4M | 363k | 20.52 |
| 2023-12-31 | $5.6M | 261k | 21.46 |
| 2022-12-31 | $37k | 1.3k | 27.81 |
| 2022-09-30 | $767k | 25k | 30.68 |
| 2021-12-31 | $574k | 13k | 44.59 |
| 2021-09-30 | $321k | 6.4k | 50.44 |
| 2021-06-30 | $8.0M | 102k | 78.44 |
| 2021-03-31 | $3.9M | 68k | 57.11 |
| 2020-12-31 | $4.2M | 50k | 83.76 |
| 2020-09-30 | $2.3M | 64k | 35.83 |
| 2020-03-31 | $950k | 54k | 17.51 |
| 2019-06-30 | $2.5M | 120k | 20.76 |